Is Stroke risk analysis (SRA) a reliable method for predicting atrial fibrillation? A systematic review

Plos One
|June 25, 2024
PubMed

Insights

Stroke Risk Analysis (SRA) software effectively identifies high-risk patients for paroxysmal atrial fibrillation, a key stroke cause. This tool aids in selecting patients for further cardiac monitoring, improving stroke risk assessment.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Informatics

Background:

  • Atrial fibrillation is a significant cause of cardioembolic stroke, contributing 17-30% of stroke etiologies.
  • Stroke Risk Analysis (SRA) software analyzes continuous electrocardiograms to identify patients at high risk for paroxysmal atrial fibrillation.

Purpose of the Study:

  • To systematically review the effectiveness of the SRA method in predicting stroke risk due to paroxysmal atrial fibrillation.
  • Evaluate SRA's role in identifying patients who may benefit from further investigation.

Main Methods:

  • Systematic review following the International Prospective Register of Systematic Reviews Protocol (CRD42021253974).
  • Searched BMJB, PubMed/MEDLINE, Science Direct, and LILACS databases.
  • Included six cohort studies with 2,088 stroke participants comparing SRA with continuous ECG monitoring (1-48h).

Main Results:

  • SRA demonstrated a high negative predictive value (96-99.1%) in detecting paroxysmal atrial fibrillation.
  • SRA can assist in selecting high-risk patients for implantable cardiac monitoring.

Conclusions:

  • Sequential use of SRA and implantable cardiac monitoring is a promising strategy for diagnosing undiagnosed paroxysmal atrial fibrillation.
  • SRA serves as a cost-effective pre-selection tool for identifying stroke patients who may benefit from implantable cardiac monitoring.
  • The absence of randomized controlled trials is a noted limitation.
Abstract